Nichols & Pratt Advisers’s Pfizer PFE Stock Holding History

Nichols & Pratt Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$637K	Hold	22,700	–	–	0.04%	71
2025 Q4	$565K	Sell	22,700 -500	-2%	-$12.6K	0.04%	76
2025 Q3	$591K	Sell	23,200 -10,799	-32%	-$267K	0.04%	77
2025 Q2	$824K	Sell	33,999 -13,986	-29%	-$326K	0.06%	71
2025 Q1	$1.22M	Sell	47,985 -2,620	-5%	-$68.6K	0.08%	65
2024 Q4	$1.34M	Sell	50,605 -1,528	-3%	-$41.4K	0.09%	64
2024 Q3	$1.51M	Hold	52,133	–	–	0.1%	64
2024 Q2	$1.46M	Sell	52,133 -1,483	-3%	-$40.8K	0.1%	61
2024 Q1	$1.49M	Sell	53,616 -201	-0.4%	-$5.58K	0.1%	61
2023 Q4	$1.55M	Sell	53,817 -1,255	-2%	-$37.9K	0.11%	61
2023 Q3	$1.83M	Sell	55,072 -3,420	-6%	-$121K	0.14%	58
2023 Q2	$2.15M	Sell	58,492 -250	-0.4%	-$9.73K	0.16%	54
2023 Q1	$2.4M	Sell	58,742 -229	-0.4%	-$9.89K	0.18%	51
2022 Q4	$3.02M	Buy	58,971 +3,789	+7%	+$182K	0.24%	52
2022 Q3	$2.42M	Buy	55,182 +1,075	+2%	+$52.2K	0.21%	53
2022 Q2	$2.84M	Hold	54,107	–	–	0.23%	51
2022 Q1	$2.8M	Hold	54,107	–	–	0.2%	53
2021 Q4	$3.19M	Sell	54,107 -4,750	-8%	-$235K	0.22%	51
2021 Q3	$2.53M	Sell	58,857 -50	-0.1%	-$2.21K	0.19%	54
2021 Q2	$2.31M	Hold	58,907	–	–	0.17%	54
2021 Q1	$2.13M	Buy	58,907 +742	+1%	+$26.3K	0.17%	54
2020 Q4	$2.14M	Sell	58,165 -3,141	-5%	-$115K	0.17%	52
2020 Q3	$2.13M	Sell	61,306 -2,240	-4%	-$78.5K	0.18%	50
2020 Q2	$1.97M	Sell	63,546 -7,095	-10%	-$241K	0.18%	52
2020 Q1	$2.19M	Buy	70,641 +10,555	+18%	+$360K	0.22%	49
2019 Q4	$2.23M	Sell	60,086 -26,389	-31%	-$940K	0.18%	54
2019 Q3	$2.95M	Sell	86,475 -561	-0.6%	-$20.4K	0.24%	53
2019 Q2	$3.58M	Buy	87,036 +2,240	+3%	+$88.9K	0.29%	50
2019 Q1	$3.42M	Buy	84,796 +402	+0.5%	+$16.1K	0.29%	49
2018 Q4	$3.5M	Sell	84,394 -5,917	-7%	-$246K	0.33%	47
2018 Q3	$3.78M	Sell	90,311 -1,581	-2%	-$60.9K	0.31%	47
2018 Q2	$3.16M	Hold	91,892	–	–	0.28%	46
2018 Q1	$3.09M	Sell	91,892 -263	-0.3%	-$9.04K	0.28%	47
2017 Q4	$3.17M	Buy	92,155 +285	+0.3%	+$9.72K	0.27%	47
2017 Q3	$3.11M	Sell	91,870 -1,091	-1%	-$35.1K	0.28%	46
2017 Q2	$2.96M	Hold	92,961	–	–	0.27%	46
2017 Q1	$3.02M	Sell	92,961 -1,686	-2%	-$53.2K	0.28%	46
2016 Q4	$2.92M	Sell	94,647 -7,139	-7%	-$218K	0.27%	46
2016 Q3	$3.27M	Sell	101,786 -317	-0.3%	-$10.6K	0.3%	46
2016 Q2	$3.41M	Sell	102,103 -3,584	-3%	-$114K	0.31%	48
2016 Q1	$2.97M	Sell	105,687 -4,824	-4%	-$138K	0.27%	51
2015 Q4	$3.38M	Sell	110,511 -15,125	-12%	-$476K	0.33%	51
2015 Q3	$3.74M	Sell	125,636 -1,346	-1%	-$43.2K	0.38%	50
2015 Q2	$4.04M	Sell	126,982 -1,404	-1%	-$45.8K	0.38%	50
2015 Q1	$4.24M	Sell	128,386 -495	-0.4%	-$15.7K	0.39%	47
2014 Q4	$3.81M	Sell	128,881 -566	-0.4%	-$16.2K	0.34%	48
2014 Q3	$3.63M	Sell	129,447 -1,217	-0.9%	-$34.2K	0.32%	50
2014 Q2	$3.68M	Sell	130,664 -57,313	-30%	-$1.63M	0.32%	50
2014 Q1	$5.73M	Buy	187,977 +50,702	+37%	+$1.51M	0.52%	44
2013 Q4	$3.99M	Sell	137,275 -2,029	-1%	-$59.1K	0.38%	49
2013 Q3	$3.8M	Sell	139,304 -12,297	-8%	-$335K	0.38%	49
2013 Q2	$4.03M	Buy	+151,601	New	+$4.19M	0.42%	47

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Nichols & Pratt Advisers's PFE Position: Q1 2026 in Review

Nichols & Pratt Advisers held its Pfizer (PFE) position steady in Q1 2026 at 22,700 shares worth $637K. The position accounts for 0.04% of the portfolio, ranked #71.

Nichols & Pratt Advisers first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.73M in Q1 2014. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Nichols & Pratt Advisers held 22,700 shares of Pfizer worth $637K as of Q1 2026.
Nichols & Pratt Advisers left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.04% of Nichols & Pratt Advisers's portfolio in Q1 2026, its #71 holding.
Nichols & Pratt Advisers first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Nichols & Pratt Advisers's Pfizer position peaked at $5.73M in Q1 2014.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2026, filed 29 Apr 2026.